FI831998L - Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat

Info

Publication number
FI831998L
FI831998L FI831998A FI831998A FI831998L FI 831998 L FI831998 L FI 831998L FI 831998 A FI831998 A FI 831998A FI 831998 A FI831998 A FI 831998A FI 831998 L FI831998 L FI 831998L
Authority
FI
Finland
Prior art keywords
pyrazinonderivat
farming
framework
pharmaceutical active
pharmaceutical
Prior art date
Application number
FI831998A
Other languages
English (en)
Finnish (fi)
Other versions
FI831998A0 (fi
Inventor
John Colin Emmett
William John Coates
Robert Antony Slater
Brian Herbert Warrington
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300476A external-priority patent/GB8300476D0/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI831998A0 publication Critical patent/FI831998A0/fi
Publication of FI831998L publication Critical patent/FI831998L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI831998A 1982-06-05 1983-06-03 Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat FI831998L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8216437 1982-06-05
GB838300476A GB8300476D0 (en) 1983-01-08 1983-01-08 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
FI831998A0 FI831998A0 (fi) 1983-06-03
FI831998L true FI831998L (fi) 1983-12-06

Family

ID=26283037

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831998A FI831998L (fi) 1982-06-05 1983-06-03 Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat

Country Status (15)

Country Link
US (2) US4514568A (fr)
EP (1) EP0096517A3 (fr)
KR (1) KR840005111A (fr)
AU (1) AU1527583A (fr)
DD (1) DD209818A5 (fr)
DK (1) DK247783A (fr)
ES (2) ES8500244A1 (fr)
FI (1) FI831998L (fr)
GR (1) GR79299B (fr)
JO (1) JO1255B1 (fr)
NO (1) NO832016L (fr)
PL (1) PL242354A1 (fr)
PT (1) PT76791B (fr)
RO (1) RO86851B (fr)
ZW (1) ZW12783A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4595766A (en) * 1984-10-26 1986-06-17 Ciba-Geigy Corporation Process for the preparation of an indoline carboxylic acid
US4697016A (en) * 1984-10-26 1987-09-29 Ciba-Geigy Corporation Intermediates for the preparation of a carboxylic acid
JPS62198671A (ja) * 1986-02-25 1987-09-02 Toyo Jozo Co Ltd 1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (fr) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
WO2010009319A2 (fr) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
CA2770454A1 (fr) * 2009-08-19 2011-02-24 Ambit Biosciences Corporation Composes biaryles et procedes d'utilisation de ceux-ci
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
KR20150023722A (ko) * 2012-06-12 2015-03-05 애브비 인코포레이티드 피리디논 및 피리다지논 유도체
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
EP2970384A1 (fr) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (fr) 2019-05-21 2020-11-26 Ardelyx, Inc. Combinaison pour baisser le phosphate sérique chez un patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745161A (en) * 1970-04-20 1973-07-10 Merck & Co Inc Phenyl-hydroxy-pyrazine carboxylic acids and derivatives

Also Published As

Publication number Publication date
GR79299B (fr) 1984-10-22
ES522962A0 (es) 1984-10-01
AU1527583A (en) 1983-12-08
PT76791B (en) 1986-01-24
EP0096517A3 (fr) 1985-04-03
FI831998A0 (fi) 1983-06-03
JO1255B1 (en) 1985-04-20
ES530024A0 (es) 1985-12-01
RO86851B (ro) 1985-05-31
ZW12783A1 (en) 1983-08-24
PL242354A1 (en) 1984-12-17
DK247783D0 (da) 1983-06-01
KR840005111A (ko) 1984-11-03
US4556711A (en) 1985-12-03
RO86851A (fr) 1985-05-20
US4514568A (en) 1985-04-30
DD209818A5 (de) 1984-05-23
DK247783A (da) 1983-12-06
ES8500244A1 (es) 1984-10-01
ES8707507A1 (es) 1985-12-01
NO832016L (no) 1983-12-06
EP0096517A2 (fr) 1983-12-21
PT76791A (en) 1983-07-01

Similar Documents

Publication Publication Date Title
FI831998L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
FI831740L (fi) Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt
FI834735A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
FI823336A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva benzamidderivat
NO843084L (no) Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater
NO833279L (no) Farmasoeytiske preparater for behandling av uoensket sammenvoksing
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO834729L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner
NO790523L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
FI821910A0 (fi) Anordning foer delning av stroemningar
FI831148A0 (fi) Foerfarande foer framstaellning av substituerade penemderivat
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
FI834736A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
BR8009059A (pt) Administracao de substancia medicas ativas
NO834437L (no) Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater
NO831995L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2-metoksyetyl)-noroksymorfon
NO832430L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater
DK314283A (da) Farmaceutiske praeparater

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: SMITH KLINE & FRENCH LABORATORIES